-
Aprovel 150 mg film-coated tablets
- admission: Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
-
Aprovel 150 mg tablets
- admission: Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
-
Aprovel 300 mg film-coated tablets
- admission: Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
-
Aprovel 300 mg tablets
- admission: Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
-
Aprovel 75 mg film-coated tablets
- admission: Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
-
Aprovel 75 mg tablets
- admission: Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Irbesartan
-
CoAprovel 150 mg/12.5 mg film-coated tablets
- admission: Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
-
CoAprovel 150 mg/12.5 mg tablets
- admission: Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
-
CoAprovel 300 mg/12.5 mg film-coated tablets
- admission: Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
-
CoAprovel 300 mg/12.5 mg tablets
- admission: Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
-
CoAprovel 300 mg/25 mg film-coated tablets
- admission: Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan
-
Competact 15 mg/850 mg film-coated tablets
- admission: Great Britain
- Producer: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BD05
- Active Substance: Hydrochloride, Metformin Hydrochloride, Pioglitazone
-
Efficib 50 mg/1,000 mg film-coated tablets
- admission: Great Britain
- Producer: Merck Sharp & Dohme Ltd.
- ATC-Code: A10BD07
- Active Substance: Hydrochloride, Metformin Hydrochloride, Sitagliptin
-
Efficib 50 mg/850 mg film-coated tablets
- admission: Great Britain
- Producer: Merck Sharp & Dohme Ltd.
- ATC-Code: A10BD07
- Active Substance: Hydrochloride, Metformin Hydrochloride, Sitagliptin
-
Eucreas 50 mg/1000 mg film-coated tablets
- admission: Great Britain
- Producer: Novartis Europharm Ltd.
- ATC-Code: A10BD08
- Active Substance: Hydrochloride, Metformin Hydrochloride, Vildagliptin
-
Eucreas 50 mg/850 mg film-coated tablets
- admission: Great Britain
- Producer: Novartis Europharm Ltd.
- ATC-Code: A10BD08
- Active Substance: Hydrochloride, Metformin Hydrochloride, Vildagliptin
-
Glubrava 15 mg/850 mg film-coated tablets
- admission: Great Britain
- Producer: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BD05
- Active Substance: Hydrochloride, Metformin Hydrochloride, Pioglitazone
-
Icandra 50 mg/1000 mg film-coated tablets
- admission: Great Britain
- Producer: Novartis Europharm Ltd.
- ATC-Code: A10BD08
- Active Substance: Hydrochloride, Metformin Hydrochloride, Vildagliptin
-
Icandra 50 mg/850 mg film-coated tablets
- admission: Great Britain
- Producer: Novartis Europharm Ltd.
- ATC-Code: A10BD08
- Active Substance: Hydrochloride, Metformin Hydrochloride, Vildagliptin
-
Ifirmacombi 150 mg/12.5 mg film-coated tablets
- admission: Great Britain
- Producer: Krka, d.d., Novo mesto
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochloride, Hydrochlorothiazide, Irbesartan
-
Ifirmacombi 300 mg/12.5 mg film-coated tablets
- admission: Great Britain
- Producer: Krka, d.d., Novo mesto
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochloride, Hydrochlorothiazide, Irbesartan
-
Ifirmacombi 300 mg/25 mg film-coated tablets
- admission: Great Britain
- Producer: Krka, d.d., Novo mesto
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochloride, Hydrochlorothiazide, Irbesartan
-
Ifirmasta 150 mg film-coated tablets
- admission: Great Britain
- Producer: Krka, d.d., Novo mesto
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochloride, Irbesartan
-
Ifirmasta 300 mg film-coated tablets
- admission: Great Britain
- Producer: Krka, d.d., Novo mesto
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochloride, Irbesartan
-
Ifirmasta 75 mg film-coated tablets
- admission: Great Britain
- Producer: Krka, d.d., Novo mesto
- ATC-Code: C09CA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochloride, Irbesartan
-
Irbesartan Hydrochlorothiazide Winthrop 150 mg/12.5 mg film-coated tablets
- admission: Great Britain
- Producer: Sanofi Pharma Bristol-Myers Squibb SNC
- ATC-Code: C09DA04
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Irbesartan